Türk tabipler Birliği
Türk Oftalmoloji Derneği
Association for Research in Vision and Ophthalmology
American Society of Cataract and Refractive Surgeons
American Academy of Ophthalmology

DERS VE SUNUMLAR:

1. An Animal Model to Evaluate the Toxicity of HPMPC for Intravitreal
Therapy of CMV Retinitis" (poster). University Wide AIDS Research
Program"12th Annual AIDS Investigators' Meeting". March 23, 1995. The
Clairon Hotel, Millbrae, California.

2. "Optic Neuritis Preceding Herpetic Necrotizing Retinitis (VAKA TAKDİMİ).
Shiley Eye Center, UCSD. (Visiting professor; Everett Ai, M.D.). November, 27,1995.

3. "Intravitreal Cidofovir (HPMPC) for the Maintenance Teatment of CMV
Retinitis" Cytomegalovirus Resistance Symposium; Critical Issues in AIDS
Research (AmFAR; guest speaker) Sheraton, Washington Hotel. January 28, 1996.

4. Koroidal Dejenerasyonlar. Academic Educational Program of the Turkish Ophthalmological Society Ankara Branch; 23rd National Ophthalmology Course. Diseases of the Uvea, (konuk konuşmacı) Hilton Hotel, Ankara; Nisan 2003, Ankara.

5. Health related quality of life and mood in patients with ocular involvement of Behçet’s syndrome. National Behçet Congress (konuk konuşmacı) 2004, İstanbul.

GÖZDEN GEÇİRİLMİŞ ESERLER:

1. Rahhal FM, Arevalo JF, Munguia D, Taskintuna I, Chavez E, Azen SP,
Freeman WR; Intravitreal cidofovir (HPMPC) for the maintenance treatment
of Cytomegalovirus retinitis. Ophthalmology 1996; 103:1078-83.

2. Taskintuna I, Banker AS, Flores-Aguilar M, Bergeron-Lynn G, Aldern KA,
Hostetler KY, Freeman WR; Evaluation of a novel lipid prodrug for intraocular
drug delivery; Effect of acyclovir diphosphate dimyristoylglycerol in a rabbit
model with Herpes Simplex Virus-1 retinitis. Retina 1997; 17:57-64

3. Studies of Ocular Complications of AIDS (SOCA) Research Group in
Collaboration with the AIDS Clinical Trials Group, Taskintuna I ; Parenteral
cidofovir for the treatment of cytomegalovirus retinitis in patients with AIDS:
The HPMPC Peripheral Cytomegalovirus Retinitis Trial. A randomized,
controlled trial. Annals of Internal Medicine 1997; 126:264-74.

4. Taskintuna I, Banker AS, Rao NA, Wiley CA, Flores-Aguilar M, Munguia D,
Bergeron-Lynn G, De Clercq E, Freeman WR; An animal model for HPMPC
(cidofovir) toxicity: Intraocular pressure and histopathologic effects. Experimental Eye Research 1997; 64:795-806.

5. Taskintuna I, Rahhal FM, Arevalo JF, Munguia D, Banker AS, Freeman WR;
Low dose intravitreal HPMPC (cidofovir) therapy for CMV retinitis in patients
with AIDS. Ophthalmology, 1997; 104:1049-57.

6. Taskintuna I, Rahhal FM, Rao NA, Wiley CA, Mueller AJ, Banker AS, De
Clercq E, Arevalo JF, Freeman WR; Adverse events and autopsy findings after
intravitreal cidofovir (HPMPC) therapy in patients with Acquired Immune
Deficiency Syndrome. Ophthalmology, 1997; 104:1827-37.

7. Davis JL, Taskintuna I, Freeman WR, Weinberg DV, Feuer WJ, Leonard RE;
Iritis and hypotony after intravenous cidofovir for CMV retinitis. Archieves of
Ophthalmology. 1997; 115:733-37.

8. Banker AS, Arevalo JF, Rahhal FM, Ishimoto B, Munguia D, Berry C, De
Clercq, Ochabski R, Taskintuna I, Freeman WR; Intraocular pressure and
aqueous humor dynamics in AIDS. American Journal of Ophthalmology, 1997; 124:168-80.

9. Mueller AJ, Plummer DJ, Dua R, Taskintuna I, Sample PA, Grant I, Freeman
WR; Analysis of visual dysfunctions in HIV-pozitive patients without retinitis.
American Journal of Ophthalmology. 1997; 124:158-67.

10. Studies of Ocular Complications of AIDS (SOCA) Research Group in
Collaboration with the AIDS Clinical Trials Group, Taskintuna I; MSL-109
adjuvant therapy for cytomegalovirus retinitis in patients with acquired
immunodeficiency syndrome. The monoclonal antibody cytomegalovirus
retinitis trial. Archieves of Ophthalmology. 1997; 115:1528-36.

11. Smith IL, Taskintuna I, Rahhal FM, Powell HC, Ai E, Mueller AJ, Spector
SA, Freeman WR; Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Archives of Ophthalmology. 1998;
116:178-85.

12. Taskintuna I, Rahhal FM, Capparelli EV, Cundy KC, Freeman WR;
Intravitreal and plasma cidofovir concentrations after intravitreal and
intravenous administration in AIDS patients with cytomegalovirus retinitis.
Journal of Ocular Pharmacologyand Therapeutics. 1998; 14:147-51.

13. Banker AS, De Clercq E, Taskintuna I, Keefe K, Bergeron-Lynn G, Freeman
WR; Influence of intravitreal injections of HPMPC-related nucleotide analogs
on intraocular pressure of guinea pig eyes. Investigative Ophthalmology &
Visual Science. 1998; 39:1233-42.

14. Banker AS, Bergeron-Lynn G, Keefe KS, De Clercq E, Taskintuna I,
Freeman WR; Effects of topical and subconjoctival cidofovir (HPMPC) in an
animal model. Current Eye Research. 1998; 17:560-66.

15. DJ Plummer, A Banker, Taskintuna I, SP Azen, PA Sample, Laurie LaBree, WR
Freeman; The utility of entoptic perimetry as a screening test for cytomegalovirus
retinitis. Archieves of Ophthalmology 1999; 117; 202-07.

16. Mueller AJ, Folberg R, Freeman WR, Bartsch D-U, Bergeron-Lynn G,
Mehaffey M, Kan-Mitchell J, Huang X, Jian G, Avila C, Taskintuna I, Cheng
L, Wang J; Evaluation of the human choroidal melanoma rabbit model for
microcirculation patterns. Exp Eye Res 1999; 68: 671-78.

17. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group, Taskintuna I; Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. AIDS 2000; Jul 28;14(11):1571-81.

18. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group, Taskintuna I; The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with Acquired Immune Deficiency Syndrome: The ganciclovir cidofovir cytomegalovirus retinitis trial. Am J Ophthalmol 2001; 131:457-67. 20.

19. Ünal M, Teke MY, Taşkıntuna İ, Fırat E; Koroid osteomlu bir olgu. Retina-Vitreus Özel Sayı Aralık 2001;1-4. (in Turkish)

20. Taşkıntuna İ, Özkan B, Teke MY, Ünal M, Fırat E; Sifilitik üveit. Retina-Vitreus Özel Sayı Aralık 2001;11-14. (in Turkish)

21. Koç F, Şen E, Demirbay P, Taskintuna I, Teke MY, Özdal P, Ortaç S, Öz Ö, Tarkan F, Fırat E; Factors influencing treatment results in pseudophakic endophthalmitis. Eur J Ophthalmol 2002; 12:34-9.

22. Ozdal PC, Ortac S, Taskintuna I, Teke MY, Firat E; Central retinal artery occlusion associated with ocular Behçet’s Disease. Eur J Ophthalmol 2002; 12:328-330.

23. Ozdal PC, Ortac S, Taskintuna I, Fırat E; Posterior segment involvement in ocular Behçet’s Disease. Eur J Ophthalmol 2002 12:424-431.

24. Mueller AJ, Maniotis AJ, Freeman WR, Bartsch D-U, Schaller UC, Bergeron-Lynn G, Cheng L, Taskintuna I, Chen X, Kan-Mitchell J, Folberg R; An orthotopic model for human choroidal melanoma in SCID mice. Microvascular Research 2002; 64:207-213.

25. Ozdal P, Ortac S, Taskintuna I, Fırat E; Long term therapy with low-dose cyclosporin-A in ocular Behcet’s disease. Documenta Ophthalmologica 2002 105:301-312.

26. Erdinç E, Demirbay P, Öz Ö, Teke MY, Taşkıntuna İ, Koç F, Köklü G, Fırat E. Katarakt cerrahisi sonrası psödofakik kistoid makula ödemi insidansı. Retina-Vitreus 2002; 10:53-59.

27. Tanriverdi N, Taskintuna I, Duru C, Ozdal P, Ortac P, Firat E; Health related quality of life and mood in patients with ocular involvement of Behçet’s syndrome. Jpn J Ophthalmol 2003; 47:85-92.

28. Taskintuna I; Visual loss in patients with cytomegolovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active retroviral therapy. Arch Ophthalmology 2003; 121:99-107.

29. Taşkıntuna İ, Öz Ö,Teke MY, Koçak H, Fırat E; Morning glory syndrome: Association with Moyamoya disease, midline cranial defects, central nervous system anomalies and persistent hyaloid artery remnant. Retina 2003;

30. Yıldız M, Şengün A, Taşkıntuna İ, Sarıcaoğlu S, Hasıripi H, Fırat E; Vogt-Koyanagi-Harada Sendromu. Oftalmoloji 2003; 10:250-55.

31. Teke MY, Önal S, Taşkıntuna İ, Mehmet Y., Şen E, Koç F, Tarkan F, Özkan B, Fırat E. İntraoküler yabancı cisimlerin neden olduğu oküler yaralanmalarda prognostik faktörler. Retina-Vitreus 2003; 11:228-234.

31. Taşkıntuna İ, Teke MY, Öz Ö, Özkan B, Yanar B, Önal S, Fırat E; Angioid streaks’e bağlı koroidal neovaskülarizasyonların (KNV) lazer fotokoagülasyon ile tedavisi. Retina-Vitreus 2004; 12:22-25.

32. Öz Ö, Teke MY, Taşkıntuna İ, Fırat E. Optik sinir avulsiyonu. Retina-Vitreus 2004; 12:136-8.

33. Şen EM, Özdal PÇ, Dansuk Z, Koç F,Taşkıntuna İ,Köklü G, Fırat E. Postoperatif endoftalmilerin değerlendirilmesi. Medikal Network Oftalmoloji 2004, 11:311-15.

34. Öz Ö, Taşkıntuna İ, Teke MY, Tarkan F, Fırat E. Jukstafoveal yerleşimli koroid neovasküler membranların lazer fotokoagülasyon ile tedavisi. Retina-Vitreus 2005; 13:103-6.

35. Kavuncu S, Taşkıntuna İ, Çakar PÖ, Ortaç S, Fırat E. Ankilozan spondilit tanısı alan hastalarda üveitin seyri. Türkiye Klinikleri Oftalmoloji 2007; 16:98-101.

36. Kavuncu S, Çakar PÖ, Ortaç S, Taşkıntuna İ, Fırat E. İdiyopatik pars planitte klinik seyir ve görsel prognoz. Medikal Network Oftalmoloji 2007; 14:184-7.

37. Yazıcı A, Özdal PÇ, Taşkıntuna İ, Kavuncu S, Köklü G. Trimethoprim/Sulfamethoxazole and azithromycin combination therapy for ocular toxoplasmosis. Ocul Immunol Inflamm 2009; 17 (4): 289-91

YAYINLANMIŞ ABSTRAKTLAR:

1. Taşkıntuna İ, Fırat E, Zilelioğlu O, Mutluay AH, Köklü G, Soykan E ;
İntraoküler lens gücü saptanmaksızın yapılan intraoküler lens implantasyonunun refraktif sonuçları. 25. Ulusal Türk Oftalmoloji Kongresi Bülteni, İstanbul 1991.

2. Taşkıntuna İ, Fırat E, Argun C, Ural F; Ekstrakapsüler katarakt ekstraksiyonu
sırasında alınan ön kamara mayii kültür sonuçları. 27. Ulusal Türk Oftalmoloji
Kogresi Bülteni, Antalya 1993.

3. Güneş S, Ortaç S, Coşkun M, Özalp S, Taşkıntuna İ, Fırat E; Behçet
Hastalığında düşük doz Cyclosporin-A tedavisinin etkinliği. 28. Ulusal Türk
Oftalmoloji Kogresi Bülteni, 1248-50, 1994

4. Taskintuna, I, Flores-Aguilar M, Tatebayashi M, Munguia D, Chavez-de la
Paz E, De Clercq E, Bergeron-Lynn G, Chandler B, Freeman WR: An
animal model of HPMPC (cidofovir) toxicity. Investigative Ophthalmology &
Visual Science, 36(Suppl) S322, 1995.

5. Taskintuna I, Rahhal FM, Arevalo, et al., Low dose intravitreal HPMPC
(cidofovir) therapy for CMV retinitis in patients with AIDS. Investigative
Ophthalmology & Visual Science, 37 (Suppl) S669, 1996.

6. Banker AS, Taskintuna I, De Clercq E, Bergeron-Lynn G, Chandler B, Freeman
WR; Influence of intravitreal injections of HPMPC related nucleotide analogues on intraocular pressure of guinea pig eyes. Investigative Ophthalmology & Visual Science, 37 (Suppl) S772, 1996.

7. Rahhal FM, Taskintuna I, Arevalo JF, Banker AS, Clarke T, Freeman WR;
Intraocular drug delivery into silicone-oil filled eyes: Experience with cidofovir
(HPMPC). Investigative Ophthalmology & Visual Science, 37(Suppl) S784, 1996.

8. Taskintuna I, Rahhal FM, Arevalo JF, Banker AS, De Clercq E, Freeman WR;
Adverse events and autopsy findings after intravitreal cidofovir (HPMPC)
therapy. Ophthalmology 103 (Suppl-9A); 136, 1996.

9. Smith IL, Flores-Aguilar M, Taskintuna I, Jiles RE, Freeman WR, Spector
SA; Cytomegalovirus resistance is associated with clinical failure in AIDS
patients receiving ganciclovir treatment for retinitis. 36th Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC); H30, 168.
New Orleans, LA, Sep 15-18, 1996.

10. Douglas Dieterich for The Studies of Ocular Complications of AIDS Research
Group; Monoclonal Antibody CMV Retinitis Trial: Preliminary Results.36th
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); New Orleans, LA, Sep 15-18, 1996.


11. Taskintuna I, Smith IL, Rahhal FM, Powell HC, Mueller AJ, Ai E, Jiles RE,
Cherrington JM, Spector SA, Freeman WR; Clinical resistance to intravitreal
cidofovir treatment in patients with AIDS-related Cytomegalovirus retinitis.
Investigative Ophthalmology & Visual Science, 38 (Suppl) S741, 1997.

12. Macdonald CJ, Taskintuna I, Rahhal FM, Munguia D, Banker AS, Freeman
WR; Intravitreal cidofovir (HPMPC) for the treatment of CMV retinitis: A dose escalating clinical trial. Investigative Ophthalmology & Visual Science, 38(Suppl) S914, 1997.

13. Mueller AJ, Bartsch D-U, Mehaffey M, Jian G, Avila CP, Taskintuna I, Kan-Mitchell J, Folberg RN, Freeman WR; Human choroidal melanoma and confocal ICG: An animal model in rabbit eyes. Investigative Ophthalmology & Visual Science, 38(Suppl) S808, 1997.

14. Smith IL, Taskintuna I, Rhett EJ, Shapiro A, Freeman WR, Spector SA;
Analysis of antiviral resistance in ocular Cytamegalovirus
International Cytomegalovirus Workshop, 1997, Alabama)

15. Taşkıntuna İ, Teke MY, Ortaç S, Çakar P, Öz Özay, Fırat E; Inflamatuar göz
hastalıklarında subtenon depo kortikosteroid enjeksiyonu ve kortikosterodlerin
enjeksiyondan sonra ekografik lokaliasyonu. 33. Ulusal Türk Oftalmoloji
Kogresi Bülteni, 208, 1999, İzmir.

16. Taşkıntuna İ, Erdinç E, Özdal P, Ortaç S, Öz Ö, Teke MY, Tarkan F, Fırat E; Pars plana vitrectomy with or without combined cataract extraction for vitreous opacity secondary to uveitis. 6. International Symposium on Ocular Inflammation Abstract book, 86, 2000, İstanbul.

17. Koç F, Şen E, Demiray P, Özdal P, Taşkıntuna İ, Teke MY, Öz Ö, Tarkan F, Ortaç S, Köklü G, Fırat E; Treatment results in pseudophakic endophthalmitis. 6. International Symposium on Ocular Inflammation Abstract book, 84, 2000, İstanbul.

18. Özdal PÇ, Ortaç S, Taşkıntuna İ, Fırat E; Long-term therapy with low dose cyclosporin-A n ocular Behçet’s disease. 6. International Symposium on Ocular Inflammation Abstract book, 80, 2000, İstanbul.

19. Erdinç E, Özdal PÇ, Ortaç S, Taşkıntuna İ, Fırat E; Cataract extraction and reasons of poor postoperative vision in ocular Behçet’s diesease. 6. International Symposium on Ocular Inflammation Abstract book, 80, 2000, İstanbul

20. Gedar ÖM, Gedar E, Tarkan F, Göka Ş, Teke MY, Öz Ö, Taşkıntuna İ, Köklü G, Fırat E; Yırtıklı retina dekolmanı cerrahisinde fonksiyonel ve anatomik başarı. 34. Ulusal Türk Oftalmoloji Kongresi Bülteni, 148, 2000, Antalya.

21. Taskintuna I, Teke MY, Tarkan F, Öz Ö, Gedar E, Fırat E; Laser photocoagulation of choroidal neovascularization in angioid streaks. 13th Congress of the European Society of Ophthalmology Abstract Book, 407, 2001, İstanbul.

22. Teke MY, Ünal M, Taskintuna I, Fırat E; A case report: Bilateral choroidal osteoma . 13th Congress of the European Society of Ophthalmology Abstract Book, 406, 2001, İstanbul.

23. Özdal PÇ, Ortaç S, Taşkıntuna İ, Fırat E; Posterior segment involvement in ocular Behçet’s disease. 13th Congress of the European Society of Ophthalmology Abstract Book, 296, 2001, İstanbul.

24. Ortaç S, Özdal P, Taşkıntuna İ, Koç F, Özal H, Fırat E; Uveitis in children. 13th Congress of the European Society of Ophthalmology Abstract Book, 302, 2001, İstanbul.

25. Tanrıverdi N, Taskintuna I, Özdal P, Ortaç S; Quality of life and mood in patients with ocular findings of Behçet’s syndrome. Spring Symposiums , Regional Meeting World Psychiatric AssociationCongress Proceeeding,67, 2001, Antalya.

26. Önal S, Teke MY, Tarkan F, Yücesan Ö, Göka Ş, Taşkıntuna İ, Şen E, Fırat E; İntraoküler yabancı cisimlerin neden oldugu oküler yaralanmalarda prognostik faktörler. 35. Ulusal Türk Oftalmoloji Kongresi Bülteni, 164, 2001, İzmir

27. Taşkıntuna İ (konuk konuşmacı); Koroid dejenerasyonu. Türk Oftalmoloji Derneği Ankara Şubesi Akademik Eğitim Programı 23. Ulusal Oftalmoloji Kursu: Uvea Hastalıkları ve Tedavisi 2003, 222-230, Ankara.

28. Tanrıverdi N, Taşkıntuna İ (konuk konuşmacı), Dürü Ç, Özdal P, Ortaç S, Fırat E; Oküler tutulumu olan Behçet hastalarında yaşam kalitesi. 9. Ulusal Behçet Hastalığı Kongresi Ocak 2004, İstanbul; Kongre Kitabı ve Programı sayfa 6.

29. Özdal P, Ortaç S, Taşkıntuna İ, Kavuncu S, Fırat E; Behçet Hastalığına bağlı göz tutulumunda arka segment bulguları. 9. Ulusal Behçet Hastalığı Kongresi Ocak 2004, İstanbul; Kongre Kitabı ve Programı sayfa 38.

30. Taşkıntuna İ, Ünal M, Tarkan F, Fırat E; Intravitreal triamcinolone for diffuse diabetic macular edema secondary to diabetic retinopathy. 4th European VitreoRetinal Society Meeting Abstract Book 151, 2004.

31. Şen EM, Taşkıntuna İ, Özdal PÇ, Yazıcı A, Tuna T, Köklü G, Fırat E. Derin subtenon Triamsinolon uygulamasının göziçi bsıncı üzerine etkileriç 40th Bulletin of National Turkish Ophthalmology Congress, 194, 2006, Antalya.

DİĞER YAYINLAR:


1. Taskintuna I, Rahhal FM, Freeman WR: Local Therapy for CMV Retinitis:
Intravitreal Cidofovir. The AIDS Reader 1996 (6) 157-60.